BVF Inc’s OnKure Therapeutics OKUR Stock Holding History

BVF Inc’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.8M	Buy	3,235,778 +1,256,806	+64%	+$5.39M	0.38%	34
2026 Q1	$8.19M	Buy	+1,978,972	New	+$6.11M	0.26%	35

Other funds holding OKUR

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BVF Inc's OKUR Position: Q2 2026 in Review

BVF Inc increased its OnKure Therapeutics (OKUR) stake by 64% in Q2 2026, buying an estimated $5.39M and bringing the position to 3,235,778 shares worth $14.8M. The position accounts for 0.38% of the portfolio, ranked #34.

BVF Inc first reported a position in OKUR in Q1 2026 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

BVF Inc held 3,235,778 shares of OnKure Therapeutics worth $14.8M as of Q2 2026.
BVF Inc bought 1,256,806 OnKure Therapeutics shares in Q2 2026, an estimated $5.39M.
OnKure Therapeutics made up 0.38% of BVF Inc's portfolio in Q2 2026, its #34 holding.
BVF Inc first reported a position in OnKure Therapeutics in Q1 2026 and has held it in 2 quarters since.
75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.